Yahoo Poland Wyszukiwanie w Internecie

Search results

  1. 17 sty 2023 · ROSEVILLE, Minn. and SAN DIEGO, Jan. 17, 2023 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, and Cibus, a leader in precision gene editing in agriculture,...

  2. 2 mar 2023 · ROSEVILLE, Minn., March 2, 2023 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, today announced operating and financial results for its fourth quarter...

  3. 1 maj 2023 · ROSEVILLE, Minn., May 1, 2023 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, today announced operating and financial results for its first quarter ended...

  4. View today's Calyxt Inc stock price and latest CLXT news and analysis. Create real-time notifications to follow any changes in the live stock price.

  5. 17 sty 2023 · New York (N.Y) – January 17, 2023 - Cellectis (Euronext Growth: ALCLS - Nasdaq: CLLS), a clinical-stage biotechnology company using its gene editing platform to deliver life-saving cell and gene therapies, announced today that Cibus Global LLC, a Delaware limited liability company (“Cibus”), and Calyxt, Inc. (NASDAQ: CLXT) (“Calyxt ...

  6. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services. Real time Calyxt (CLXT) stock price quote, stock graph, news & analysis.

  7. 6 mar 2023 · Signed Agreement with Global Infrastructure Partner to Enable Growth and Scale of Calyxts Proprietary Plant Cell Matrix and BioFactory Technologies. Additional Updates.

  1. Ludzie szukają również